ADA Scientific Sessions 2025 Abstract
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LAE102 in Healthy Volunteers
Trial in peopleInterventions
The paper
Shanghai
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, late-breaking 2205-LB



